MOLECULAR CANCER THERAPEUTICS Journal

publication venue for

The Methyltransferases METTL7A and METTL7B Confer Resistance to Thiol-Based Histone Deacetylase Inhibitors. 23:464-477. 2024
The Methyltransferases METTL7A and METTL7B Confer Resistance to Thiol-Based Histone Deacetylase Inhibitors. 23:464-477. 2024
Phase I Open-Label Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Dilpacimab in Patients with Advanced Solid Tumors. 20:1988-1995. 2021
Quercetin Targets hnRNPA1 to Overcome Enzalutamide Resistance in Prostate Cancer Cells. 16:2770-2779. 2017
Niclosamide and Bicalutamide Combination Treatment Overcomes Enzalutamide- and Bicalutamide-Resistant Prostate Cancer. 16:1521-1530. 2017
Quercetin Targets hnRNPA1 to Overcome Enzalutamide Resistance in Prostate Cancer Cells. 16:2770-2779. 2017
NF-κB2/p52:c-Myc:hnRNPA1 Pathway Regulates Expression of Androgen Receptor Splice Variants and Enzalutamide Sensitivity in Prostate Cancer. 14:1884-1895. 2015
Inhibition of ABCB1 Expression Overcomes Acquired Docetaxel Resistance in Prostate Cancer. 12:1829-1836. 2013
NF-κB2/p52 Induces Resistance to Enzalutamide in Prostate Cancer: Role of Androgen Receptor and Its Variants. 12:1629-1637. 2013
Overexpression of Asparagine Synthetase and Matrix Metalloproteinase 19 Confers Cisplatin Sensitivity in Nasopharyngeal Carcinoma Cells. 12:2157-2166. 2013
Overlapping Functions of ABC Transporters in Topotecan Disposition as Determined in Gene Knockout Mouse Models. 12:1343-1355. 2013
Length of mitotic arrest induced by microtubule-stabilizing drugs determines cell death after mitotic exit. 8:1646-1654. 2009
Length of mitotic arrest induced by microtubule-stabilizing drugs determines cell death after mitotic exit. 8:1646-1654. 2009
A new mechanism of drug resistance in breast cancer cells: fatty acid synthase overexpression-mediated palmitate overproduction. 7:263-270. 2008
Mechanisms of selenium down-regulation of androgen receptor signaling in prostate cancer. 5:913-918. 2006

category

ONCOLOGY Category

International Standard Serial Number (ISSN)

1535-7163

Electronic International Standard Serial Number (EISSN)

1538-8514

journal abbreviation

MOL CANCER THER